Références

Information sur le cancer / Types de cancer / Poumon / Traitement / Traitement ciblé

American Cancer Society. (2016, May). Lung Cancer (Non-Small Cell). Extrait de: http://www.cancer.org/acs/groups/cid/documents/webcontent/003115-pdf.pdf.

Cancer Care Ontario. Drug Formulary. Toronto, ON: Cancer Care Ontario.

Detterbeck FC, Decker RH, Tanoue L, Lilenbaum RC. Non-small cell lung cancer. DeVita VT Jr, Lawrence TS, Rosenberg SA. (2015). Cancer: Principles and Practice of Oncology. (10th Édition). Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins. 41: 495-535.

Drugs and Health Products, Health Canada. (2017, August 27). Regulatory Decision Summary: Xalkori. Extrait de: https://hpr-rps.hres.ca/reg-content/regulatory-decision-summary-detail.php?lang=en&linkID=RDS00285.

Ellis PM, Coakley N, Feld R, Kuruvilla S, Ung YC. Use of the epidermal growth factor receptor inhibitors gefitinib (Iressa), erlotinib (Tarceva), afatinib, dacomitinib or icotinib in the treatment of non-small cell lung cancer: a clinical practice guideline. (2014, May 8). Evidence-Based Series (EBS) and Practice Guidelines (PG). Toronto, ON: Cancer Care Ontario. No.: 7-9 Version 2.

Health Canada. (2018, June 5). Regulatory Decision Summary - Zykadia. Extrait de: https://hpr-rps.hres.ca/reg-content/regulatory-decision-summary-detail.php?lang=en&linkID=RDS00387.

National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Non-Small Cell Lung Cancer (Version 4.2016). Extrait de: http://www.nccn.org/professionals/physician_gls/f_guidelines.asp.

Princess Margaret Cancer Centre. (2015, September). Princess Margaret Cancer Centre Clinical Practice Guidelines: Lung Cancer. Extrait de: http://www.uhn.ca/PrincessMargaret/Health_Professionals/Programs_Departments/Lung/Documents/CPG_Lung_LungCancer.pdf.

Saskatchewan Cancer Agency. (2015, April 1). Provincial Non-Small Cell Lung Cancer Treatment Guidelines. (Updated Édition).

VanderMeer R, Chambers, S, Van Dam A, Cutz JC, Goffin JR. Diagnosing lung cancer in the 21st century: are we ready to meet the challenge of individualized care?. (2015). Current Oncology. 22(4): 272-278.

×
×